Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Closure of Trading Window

 Pursuant to the Company's 'Code of Conduct for Prevention of Insider Trading' read with 'Code of Conduct for Practices and Procedures Fair Disclosure of Unpublished Price Sensitive Information (UPSI)', the Trading Window for dealing in the securities of the Company will remain closed for all insiders including designated persons and their immediate relatives from Thursday, April 01, 2021 till 48 hours after announcement of Audited Financial Results/Statements for the Quarter & year ending on March 31, 2021 to the Stock Exchanges. The details of the date of Board meeting, in which the said results will be considered, shall be intimated in due course.
31-03-2021
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Shareholding for the Period Ended February 05, 2021

 JHS Svendgaard Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended February 05, 2021. For more details, kindly Click here
17-02-2021
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 We hereby enclose copies of newspapers publications of Un-audited Financial Results of the Company for the quarter & nine months ended December 31, 2020, published on February 10, 2021 in Mint (English) and Business Standard (Hindi).
10-02-2021
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Announcement under Regulation 30 (LODR)-Allotment

 In accordance with Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations, 2015'), we wish to inform your good office that the Board of Directors of the Company, JHS Svendgaard Laboratories Limited, at their meeting held today i.e., Tuesday, February 09, 2021, at New Delhi, has, inter alia, considered and approved the: I. Unaudited Financial Results (Standalone as well as Consolidated) of the Company for the quarter and nine months ended on December 31, 2020. Copies of the such results along with Limited Review Reports thereon are enclosed as Annexure - A. II. Allotment of 35,00,000 (Thirty-Five Lakh) Equity Shares of face value of Rs. 10/- each pursuant to conversion of 35,00,000 Fully Convertible Warrants ('Warrants'), issued as on September 22, 2020 at an issue price of Rs. 20/- each, by way of preferential allotment on a private placement basis, to the persons belonging to 'Non-Promoter' category:
09-02-2021
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Outcome Of Meeting Of Board Of Directors In Accordance With Reg. 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 In accordance with Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations, 2015'), we wish to inform your good office that the Board of Directors of the Company, JHS Svendgaard Laboratories Limited, at their meeting held today i.e., Tuesday, February 09, 2021, at New Delhi, has, inter alia, considered and approved the: I. Unaudited Financial Results (Standalone as well as Consolidated) of the Company for the quarter and nine months ended on December 31, 2020. Copies of the such results along with Limited Review Reports thereon are enclosed as Annexure - A. II. Allotment of 35,00,000 (Thirty-Five Lakh) Equity Shares of face value of Rs. 10/- each pursuant to conversion of 35,00,000 Fully Convertible Warrants ('Warrants'), issued as on September 22, 2020 at an issue price of Rs. 20/- each, by way of preferential allotment on a private placement basis, to the persons belonging to 'Non-Promoter' category:
09-02-2021
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Outcome Of Meeting Of Board Of Directors In Accordance With Reg. 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 In accordance with Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations, 2015'), we wish to inform your good office that the Board of Directors of the Company, JHS Svendgaard Laboratories Limited, at their meeting held today i.e., Tuesday, February 09, 2021, at New Delhi, has, inter alia, considered and approved the: I. Unaudited Financial Results (Standalone as well as Consolidated) of the Company for the quarter and nine months ended on December 31, 2020. Copies of the such results along with Limited Review Reports thereon are enclosed as Annexure - A. II. Allotment of 35,00,000 (Thirty-Five Lakh) Equity Shares of face value of Rs. 10/- each pursuant to conversion of 35,00,000 Fully Convertible Warrants ('Warrants'), issued as on September 22, 2020 at an issue price of Rs. 20/- each, by way of preferential allotment on a private placement basis, to the persons belonging to 'Non-Promoter' category:
09-02-2021
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In continuation of our letter dated February 01, 2021 we enclose copies of the advertisements published on February 02, 2021, in Business Standard (English) and Business Standard (Hindi) with respect to the Notice of the Board Meeting scheduled to be held on 09th February, 2021.
02-02-2021
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Board Meeting Intimation for Intimation Of Board Meeting

 JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, this is to inform you that a meeting of the Board of Directors of JHS Svendgaard Laboratories Limited (the Company) is scheduled to be held on Tuesday, 09th February, 2021, inter-alia, to consider and approve the Un-audited Financial Results (Standalone & Consolidated) of the Company for the quarter & nine months ended December 31, 2020. In this connection, as per the Company's Code of Practices & Procedures for fair Disclosure of Unpublished Price Sensitive Information pursuant to SEBI (Prohibition of Insider Trading), Regulations, 2015 the Trading window for dealing in securities of the Company for all Insiders, which is closed from 1st January, 20201, will remain closed till 48 hours after the announcement of outcome of the Board Meeting (both days inclusive).
01-02-2021
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Shareholding for the Period Ended December 31, 2020

 JHS Svendgaard Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here
21-01-2021
Bigul

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We hereby submit the confirmation certificate dated 19th January, 2021 received from M/s. Alankit Assignments Limited, Registrar and Share Transfer Agent (RTA) of our Company as per Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations, 2018 for the quarter ended 31st December, 2020.
20-01-2021
Next Page
Close

Let's Open Free Demat Account